These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33606956)

  • 41. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.
    Pirola CJ; Sookoian S
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32407757
    [No Abstract]   [Full Text] [Related]  

  • 43. Arterial hypertension and the risk of severity and mortality of COVID-19.
    Leiva Sisnieguez CE; Espeche WG; Salazar MR
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32398296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
    Satoh K; Kikuchi N; Kurosawa R; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1504-1506. PubMed ID: 31339778
    [No Abstract]   [Full Text] [Related]  

  • 45. The incidence of pulmonary hypertension is higher in systemic lupus and Sjögren's patients than in scleroderma patients in China.
    Fox RI
    Lupus; 2018 Jun; 27(7):1051-1052. PubMed ID: 29732959
    [No Abstract]   [Full Text] [Related]  

  • 46. Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
    Aman J; Hovingh GK
    Thorax; 2019 Apr; 74(4):317-318. PubMed ID: 30679265
    [No Abstract]   [Full Text] [Related]  

  • 47. Inverse association between hypertension treatment and COVID-19 prevalence in Japan.
    Kinoshita M; Sato K; Vellingiri B; Green SJ; Tanaka M
    Int J Infect Dis; 2021 Jul; 108():517-521. PubMed ID: 34089886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-World Data for Pulmonary Arterial Hypertension.
    Elliott CG
    Chest; 2019 Apr; 155(4):653-654. PubMed ID: 30955564
    [No Abstract]   [Full Text] [Related]  

  • 49. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
    Maron BA; Humbert M
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32646896
    [No Abstract]   [Full Text] [Related]  

  • 50. High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia.
    Wiltshire E; Peña AS; MacKenzie K; Shaw G; Couper J
    Med Hypotheses; 2020 Oct; 143():110142. PubMed ID: 32759013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arterial stiffness and COVID-19: A bidirectional cause-effect relationship.
    Saeed S; Mancia G
    J Clin Hypertens (Greenwich); 2021 Jun; 23(6):1099-1103. PubMed ID: 33951308
    [No Abstract]   [Full Text] [Related]  

  • 52. Pregnancy still contraindicated in pulmonary arterial hypertension related to congenital heart disease: True or false?
    Ntiloudi D; Giannakoulas G
    Eur J Prev Cardiol; 2019 Jul; 26(10):1064-1066. PubMed ID: 30717604
    [No Abstract]   [Full Text] [Related]  

  • 53. Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
    Austin ED; Hamid R
    Am J Respir Crit Care Med; 2020 Jun; 201(11):1329-1331. PubMed ID: 32053755
    [No Abstract]   [Full Text] [Related]  

  • 54. Pulmonary arterial hypertension and pulmonary hypertension due to left heart disease: so near and yet so far.
    Scagliola R
    Pol Arch Intern Med; 2020 Apr; 130(4):349-350. PubMed ID: 32383838
    [No Abstract]   [Full Text] [Related]  

  • 55. Investigation and management of pulmonary embolism 2: specific clinical conditions.
    Stolberg S; Mudawi D; Dean K; Cheng A; Barraclough R
    Br J Hosp Med (Lond); 2021 Jul; 82(7):1-6. PubMed ID: 34338010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Post-COVID-19 pulmonary sequla: longterm follow up and management].
    Türktaş H; Oğuzülgen İK
    Tuberk Toraks; 2020 Dec; 68(4):419-429. PubMed ID: 33448739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective.
    John Wort S; Arachchillage DJ; McCabe C; Price LC
    Respir Med Res; 2020 Nov; 78():100781. PubMed ID: 32889497
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistence of SARS-CoV-2: a new paradigm of COVID-19 management.
    Alhusseini LB; Yassen LT; Kouhsari E; Al Marjani MF
    Ann Ig; 2021; 33(5):426-432. PubMed ID: 33443283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "Rehab for all!" Is it too early in pulmonary arterial hypertension?
    Bertoletti L; Bouvaist H; Tromeur C; Bezzeghoud S; Dauphin C; Enache I; Bourdin A; Seronde MF; Montani D; Turquier S; Pison C; ;
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31699779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.